Public Health On Call

726 - Substandard and Fake Drugs

02.28.2024 - By Johns Hopkins Bloomberg School of Public HealthPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Imagine going to the pharmacy to buy a needed medicine and then finding out you purchased a falsified product that was, at best, ineffective, but at worst contained something toxic or deadly? This is the unfortunate reality in many places worldwide. Dr. Murray Lumpkin, who leads global regulatory systems for the Bill & Melinda Gates Foundation, talks with Lindsay Smith Rogers about the substantial problem of substandard and falsified drugs, and what the world’s watchdog systems are trying to do to counter them.

More episodes from Public Health On Call